Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
Study NCT ID:
NCT01990534
Status:
COMPLETED
Last Update Posted:
2021-04-09
First Post:
2013-11-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-15
First Submit QC Date:
None
Study First Post Date:
2013-11-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-23
Results First Submit QC Date:
None
Results First Post Date:
2017-05-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-10
Last Update Post Date:
2021-04-09
Last Update Post Date Type:
ACTUAL